BOSTON & PERTH, Australia--(BUSINESS WIRE)--Global bio-nanotech company pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI) today announced that it has entered into an agreement with its principal institutional lender whereby the lender has agreed to a general forbearance with respect to any defaults through to and including the earlier of the closing of the Nordic Biotech Advisors (Nordic) transaction or March 31, 2007, subject to the satisfaction of closing conditions:
